Trimeric binding proteins for trimeric cytokines
Details for Australian Patent Application No. 2003277828 (hide)
International Classifications
Event Publications
26 February 2004 Complete Application Filed
Priority application(s): PA 2002 01634 29.10.02 DK; 60/421,807 29.10.02 US
24 June 2004 Application Open to Public Inspection
Published as AU-B-2003277828
14 December 2006 Change of Name(s) of Applicant(s), Section 104
Borean Pharma A/S The name of the applicant has been changed to Roche Bio Denmark A/S
15 March 2007 Assignment before Grant
Roche Bio Denmark A/S The application has been assigned to Borean Pharma ApS
13 November 2008 Assignment before Grant
Borean Pharma ApS The application has been assigned to Anaphore, Inc.
4 June 2009 Application Accepted
Published as AU-B-2003277828
1 October 2009 Standard Patent Sealed
24 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser